325 related articles for article (PubMed ID: 16210333)
1. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.
Landgren O; Gridley G; Turesson I; Caporaso NE; Goldin LR; Baris D; Fears TR; Hoover RN; Linet MS
Blood; 2006 Feb; 107(3):904-6. PubMed ID: 16210333
[TBL] [Abstract][Full Text] [Related]
2. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.
Brown LM; Gridley G; Check D; Landgren O
Blood; 2008 Apr; 111(7):3388-94. PubMed ID: 18239085
[TBL] [Abstract][Full Text] [Related]
3. Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma.
Kristinsson SY; Fears TR; Gridley G; Turesson I; Mellqvist UH; Björkholm M; Landgren O
Blood; 2008 Nov; 112(9):3582-6. PubMed ID: 18559977
[TBL] [Abstract][Full Text] [Related]
4. Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
Chang SH; Luo S; Thomas TS; O'Brian KK; Colditz GA; Carlsson NP; Carson KR
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040690
[TBL] [Abstract][Full Text] [Related]
5. Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection.
Konstantinopoulos PA; Pantanowitz L; Dezube BJ
J Natl Med Assoc; 2006 Nov; 98(11):1860-1. PubMed ID: 17128699
[TBL] [Abstract][Full Text] [Related]
6. Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit.
Bumma N; Nagasaka M; Hemingway G; Miyashita H; Chowdhury T; Kim S; Vankayala HM; Ahmed S; Jasti P
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):305-311. PubMed ID: 32144026
[TBL] [Abstract][Full Text] [Related]
7. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.
Greenberg AJ; Vachon CM; Rajkumar SV
Leukemia; 2012 Apr; 26(4):609-14. PubMed ID: 22193966
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
[TBL] [Abstract][Full Text] [Related]
9. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.
Landgren O; Weiss BM
Leukemia; 2009 Oct; 23(10):1691-7. PubMed ID: 19587704
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women.
Landgren O; Rajkumar SV; Pfeiffer RM; Kyle RA; Katzmann JA; Dispenzieri A; Cai Q; Goldin LR; Caporaso NE; Fraumeni JF; Blot WJ; Signorello LB
Blood; 2010 Aug; 116(7):1056-9. PubMed ID: 20421448
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men.
Cicero KI; Joffe M; Patel M; Chiuzan C; Pentz A; Ruff P; Lentzsch S; Leng S; Jacobson JS; Rebbeck TR; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2192-2198. PubMed ID: 36126958
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
13. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of monoclonal gammopathies].
Hurez D
Rev Prat; 1993 Feb; 43(3):271-4. PubMed ID: 8502953
[TBL] [Abstract][Full Text] [Related]
15. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.
Zwick C; Held G; Auth M; Bernal-Mizrachi L; Roback JD; Sunay S; Iida S; Kuroda Y; Sakai A; Ziepert M; Ueda R; Pfreundschuh M; Preuss KD
Int J Cancer; 2014 Aug; 135(4):934-8. PubMed ID: 24443359
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
[TBL] [Abstract][Full Text] [Related]
18. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
[TBL] [Abstract][Full Text] [Related]
19. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
20. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
Uchida M; Taida N; Kanao M; Kagamihara H; Kuwajima M
Rinsho Byori; 2004 Jul; 52(7):574-9. PubMed ID: 15344556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
